UBS: lowered Ali's health rating to neutral and lowered the target price to HK $7.8

Healthcare Dec 18, 2021 06:09 AM (GMT+8) · EqualOcean

Financial Associated Press, Dec. 18 (Reuters) - UBS issued a report to update its financial forecast for Ali health, downgraded its share rating from buy to neutral, and lowered its target price from HK $26 to HK $7.8.

This text is a result of machine translation.

Related companies：

Ali Health

Briefing Feb 21, 2023 11:10 AM · Healthcare

We-Linking Raised Over CNY 10 Mn in Angel Round

Briefing Feb 21, 2023 10:07 AM · Healthcare

Intraoperative Neurophysiological Monitoring Equipment Developer NeuroFlag Closed An Angel Round

In-depth

Healthcare

Alibaba and JD.com's Healthcare Units Prepare for Next Battle in Critical Industry

Affected heavily by recent technological advancements, the sector may soon attract Chinese regulators' attention.

Dec 20, 2021 10:43 AM

Briefing Feb 16, 2023 12:51 PM · Healthcare

Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A

Briefing Feb 15, 2023 12:32 PM · Healthcare

ZD Medtech Raised Over CNY 100 Mn in Series B

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Healthcare

China's Aesthetic Medicine Body Contouring Industry

Apr 18, 2022 06:30 PM

Briefing Feb 13, 2023 12:54 PM · Healthcare

Smart Powered Bionic Prosthetic Star BionicM Nets Over CNY 10 Mn

Briefing Jan 25, 2022 02:30 PM · Healthcare | Automotive

Japan launched measures to curb oil prices for the first time, with a subsidy of 3.4 yen per liter

Briefing Jan 17, 2022 11:19 AM · Financials | Technology | Consumer Staples

Almond milk brand "namely apricot" completed an angel round of financing of RMB 10 million

Briefing Oct 15, 2021 05:24 PM · Healthcare

New drugs will be on the shelves in three days at the fastest, and Ali health pharmacy starts the "new drug launch support plan"

Healthcare

Smart Pathology Company KfBio Nets Over CNY 100 Mn in Series C Round

There are remaining 'unmet clinical needs' in pathology diagnosis. We expect KfBio and its counterparts could offer high-quality solutions to boost the development of the pathology industry.

Jul 12, 2022 05:47 PM

Technology, Healthcare

Alibaba Ups Stake in Health Venture to 57.06%

The increase in shares shows the e-commerce giant’s confidence in the healthy and long-term development of the company, the source said

May 23, 2022 09:24 PM

Briefing Aug 04, 2021 10:14 AM · Healthcare

Hong Kong stocks Ali concept stocks strengthened. Ali health rose 5.1%

Briefing Jul 29, 2021 09:48 AM · Technology | Healthcare | Industrials

Uniswap may plan to work with Robin Hood and has contacted a large number of financial or technology companies

Briefing Jul 09, 2021 01:44 PM · Healthcare | Real Estate | Financials

Livermore securities data show that up to now, the net inflow of southward funds has reached 2 billion yuan.

In-depth